Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Microbiol Spectr ; 9(3): e0073921, 2021 12 22.
Article in English | MEDLINE | ID: mdl-34937180

ABSTRACT

Antimicrobial resistance (AMR) has become a serious public and economic threat. The rate of bacteria acquiring AMR surpasses the rate of new antibiotics discovery, projecting more deadly AMR infections in the future. The Pathogen Box is an open-source library of drug-like compounds that can be screened for antibiotic activity. We have screened molecules of the Pathogen Box against Vibrio cholerae, the cholera-causing pathogen, and successfully identified two compounds, MMV687807 and MMV675968, that inhibit growth. RNA-seq analyses of V. cholerae after incubation with each compound revealed that both compounds affect cellular functions on multiple levels including carbon metabolism, iron homeostasis, and biofilm formation. In addition, whole-genome sequencing analysis of spontaneous resistance mutants identified an efflux system that confers resistance to MMV687807. We also identified that the dihydrofolate reductase is the likely target of MMV675968 suggesting it acts as an analog of trimethoprim but with a MIC 14-fold lower than trimethoprim in molar concentration. In summary, these two compounds that effectively inhibit V. cholerae and other bacteria may lead to the development of new antibiotics for better treatment of the cholera disease. IMPORTANCE Cholera is a serious infectious disease in tropical regions causing millions of infections annually. Vibrio cholerae, the causative agent of cholera, has gained multi-antibiotic resistance over the years, posing greater threat to public health and current treatment strategies. Here we report two compounds that effectively target the growth of V. cholerae and have the potential to control cholera infection.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cholera/drug therapy , Drug Evaluation, Preclinical/methods , Folic Acid Antagonists/pharmacology , Vibrio cholerae/drug effects , Drug Resistance, Multiple, Bacterial/genetics , Genome, Bacterial/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Trimethoprim/analogs & derivatives , Trimethoprim/pharmacology , Vibrio cholerae/genetics , Vibrio cholerae/growth & development , Whole Genome Sequencing
2.
Cell Rep ; 31(11): 107766, 2020 06 16.
Article in English | MEDLINE | ID: mdl-32553162

ABSTRACT

The type VI secretion system (T6SS) is a lethal microbial weapon that injects a large needle-like structure carrying toxic effectors into recipient cells through physical penetration. How recipients respond to physical force and effectors remains elusive. Here, we use a series of effector mutants of Vibrio cholerae to determine how T6SS elicits response in Pseudomonas aeruginosa and Escherichia coli. We show that TseL, but no other effectors or physical puncture, triggers the tit-for-tat response of P. aeruginosa H1-T6SS. Although E. coli is sensitive to all periplasmically expressed effectors, P. aeruginosa is most sensitive to TseL alone. We identify a number of stress response pathways that confer protection against TseL. Physical puncture of T6SS has a moderate inhibitory effect only on envelope-impaired tolB and rseA mutants. Our data reveal that recipient cells primarily respond to effector toxicity but not to physical contact, and they rely on the stress response for immunity-independent protection.


Subject(s)
Bacterial Proteins/metabolism , Escherichia coli/metabolism , Type VI Secretion Systems/metabolism , Vibrio cholerae/metabolism , Immunity/immunology , Pseudomonas aeruginosa/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL